share_log

Analysts Are More Bearish On Vicor Corporation (NASDAQ:VICR) Than They Used To Be

アナリストたちは、以前よりもバイコア・コーポレーション(NASDAQ:VICR)について弱気見通しを示している

Simply Wall St ·  02/29 04:22

Today is shaping up negative for Vicor Corporation (NASDAQ:VICR) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Both revenue and earnings per share (EPS) estimates were cut sharply as the analysts factored in the latest outlook for the business, concluding that they were too optimistic previously.

Following the latest downgrade, the three analysts covering Vicor provided consensus estimates of US$353m revenue in 2024, which would reflect an uneasy 13% decline on its sales over the past 12 months. Statutory earnings per share are supposed to plummet 73% to US$0.32 in the same period. Previously, the analysts had been modelling revenues of US$440m and earnings per share (EPS) of US$1.19 in 2024. Indeed, we can see that the analysts are a lot more bearish about Vicor's prospects, administering a measurable cut to revenue estimates and slashing their EPS estimates to boot.

earnings-and-revenue-growth
NasdaqGS:VICR Earnings and Revenue Growth February 29th 2024

The consensus price target fell 41% to US$41.00, with the weaker earnings outlook clearly leading analyst valuation estimates.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Vicor's past performance and to peers in the same industry. We would highlight that sales are expected to reverse, with a forecast 13% annualised revenue decline to the end of 2024. That is a notable change from historical growth of 10% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 7.7% annually for the foreseeable future. It's pretty clear that Vicor's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Vicor. Regrettably, they also downgraded their revenue estimates, and the latest forecasts imply the business will grow sales slower than the wider market. Given the scope of the downgrades, it would not be a surprise to see the market become more wary of the business.

Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. At Simply Wall St, we have a full range of analyst estimates for Vicor going out to 2025, and you can see them free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする